Naomi Fersht Selected Research

Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))

1/2021

Genomic Prognosticators and Extent of Resection in Molecularly Subtyped World Health Organization Grade II and III Gliomas-A Single-Institution, Nine-Year Data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naomi Fersht Research Topics

Disease

3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 04/2016
2	Meningioma (Meningiomas) 01/2019 - 03/2013
2	Pituitary Neoplasms (Pituitary Adenoma) 12/2017 - 12/2014
1	Glioma (Gliomas) 01/2021
1	Combined Pituitary Hormone Deficiency 01/2021
1	Paraganglioma (Paragangliomas) 12/2017
1	Neoplasm Metastasis (Metastasis) 04/2016
1	Primitive Neuroectodermal Tumors (PNET) 04/2016
1	Carcinoma (Carcinomatosis) 12/2014
1	Adenoma (Adenomas) 12/2014
1	Vision Disorders (Hemeralopia) 03/2013
1	Craniopharyngioma (Craniopharyngiomas) 03/2013

Drug/Important Bio-Agent (IBA)

2	Temozolomide (Temodar)FDA LinkGeneric 12/2017 - 04/2016
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2017
1	Radioisotopes (Radionuclides)IBA 12/2014
1	LutetiumIBA 12/2014
1	Peptide Receptors (Peptide Receptor)IBA 12/2014

Therapy/Procedure

5	Radiotherapy 01/2021 - 03/2013
1	Adjuvant Radiotherapy 01/2019
1	Drug Therapy (Chemotherapy) 12/2017
1	Craniospinal Irradiation 04/2016
1	Therapeutics 12/2014